Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "FDA Process Validation Guidance & Requirements Training Course (June 24th - June 25th, 2026)" has been added to ResearchAndMarkets.com's offering.
Research and Markets has made the recording of “FDA Process Validation Guidance & Requirements Training Course” available for on-demand purchase. The course, led by Barry A. Friedman, was held live on June 24-25, 2026. It works through the FDA’s January 2011 Process Validation guidance and its three-stage lifecycle approach. It also aims to deepen participants’ understanding of Continued Process Verification, the stage manufacturers most often find hardest to put into practice.
Key Event Facts
- Course: FDA Process Validation Guidance & Requirements Training Course
- Format: Recorded training, accessed online through a secure website
- Original live event: June 24-25, 2026 (EST)
- Speaker: Barry A. Friedman
- Regulatory focus: FDA Process Validation guidance (January 2011), EU GMP Annex 15, ICH Q8(R2), Q9 and Q10
Day 1: Guidance Scope, Stage 1 and Clinical Supply
The course opens with key definitions and why process validation matters in the drug industry. It then sets out the scope of the guidance and its legal and regulatory requirements, and explains how the three stages of process validation interact. Participants examine Stage 1 process design, and process validation and cGMP in clinical supply manufacturing, including Phase 1 investigational medicinal products. Special cases are covered, including multi-product facilities, biotech processes and sterile or aseptic products. The day closes with regulatory strategy for Phases 2 and 3, and designing processes for reproducibility.
Day 2: Process Qualification and Continued Process Verification
The second day covers Stage 2 process qualification. Topics include equipment and utilities requirements, facility design, environmental monitoring, water systems and protocol review. Participants then turn to Stage 3, continued process verification, using FDA warning letters as examples. The course compares EU GMP Annex 15 with the FDA guidance, and addresses concurrent process performance qualification (PPQ) batches, systematic critical review, stability programmes, and analytical method validation and monitoring.
Why You Should Watch
- Understand the scope and regulatory requirements of the FDA’s 2011 Process Validation guidance
- Apply the three-stage lifecycle approach, from process design to continued process verification
- Address special cases, including sterile, aseptic and biotech products and multi-product facilities
- Learn from FDA warning letter examples when building a Stage 3 programme
- Align FDA and EU expectations through a comparison with EU GMP Annex 15
Featured Speaker
- Barry A. Friedman
Pharmaceutical manufacturing, validation and quality professionals can purchase the recording through Research and Markets at https://www.researchandmarkets.com/r/jum3m2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.